Stage III Lung Cancer
Also known as: Lung Cancer Stage III / Cancer of lung stage III / Lung carcinoma stage III / Carcinoma of lung stage III / Pulmonary carcinoma stage III / Lung carcinoma cell type unspecified stage III / Carcinoma of lung cell type unspecified stage III / Pulmonary carcinoma cell type unspecified stage III
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11714 | Durvalumab | 1 | Not Yet Recruiting | 1 |
| DB12257 | Platinum | 1 | Not Yet Recruiting | 1 |
| DB00062 | Albumin human | 1 / 2 | Suspended | 1 |
| DB11595 | Atezolizumab | 1 / 2 | Suspended | 1 |
| DB00958 | Carboplatin | 1 / 2 | Suspended | 1 |
| DB14707 | Cemiplimab | 1 / 2 | Suspended | 1 |
| DB06186 | Ipilimumab | 1 / 2 | Suspended | 1 |
| DB09035 | Nivolumab | 1 / 2 | Suspended | 1 |
| DB01229 | Paclitaxel | 1 / 2 | Suspended | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Suspended | 1 |
| DB00642 | Pemetrexed | 1 / 2 | Suspended | 1 |
| DB00112 | Bevacizumab | 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 3 |
| DB08904 | Certolizumab pegol | 2 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Recruiting | 2 |
| DB11714 | Durvalumab | 2 | Active Not Recruiting | 2 |
| DB00773 | Etoposide | 2 | Active Not Recruiting | 1 |
| DB00773 | Etoposide | 2 | Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 2 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB00642 | Pemetrexed | 2 | Recruiting | 2 |
| DB12257 | Platinum | 2 | Active Not Recruiting | 1 |
| DB15765 | Sintilimab | 2 | Recruiting | 1 |
| DB16640 | Almonertinib | 2 / 3 | Not Yet Recruiting | 1 |
| DB11714 | Durvalumab | Not Available | Active Not Recruiting | 1 |